Reducible and degradable nano medicine-carrying micelle and preparation method thereof
A nano-drug-loading and micelle technology, applied in the field of biomedical technology and nano-medicine, can solve problems such as the concentration difference of glutathione, improve clinical efficacy and bioavailability, efficient delivery and localized release, and efficient method. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0031] A method for preparing reductively degradable nano drug-loaded micelles, comprising the steps of:
[0032] The first step: use the Michael addition of N,N'-bis(acryloyl)cystamine and ethanolamine to obtain polycystamine with a disulfide bond with a hydroxyl group, and then use the hydroxyl group to perform a ring-opening reaction on caprolactone to obtain CA -PCL polymer; can be divided into three steps for above reaction:
[0033](1): Substitution reaction of cystamine dihydrochloride and acryloyl chloride to obtain N, N'-bis(acryloyl) cystamine (CBA): 10mmol cystamine dihydrochloride (cysteamine hydrochloride) dissolved in In a mixed solution containing 10mL chloroform and 15mL, 3.5M NaOH, heat to 50°C, add 5mL chloroform containing 20mmol acryloyl chloride dropwise, react for 15min, and keep the temperature of the reaction solution at 50°C; then filter and extract while hot, and take Cool the organic phase to room temperature to obtain a white crystalline solid, fil...
Embodiment 2
[0041] With the experimental method of embodiment 1, fix the amount of polycystamine containing disulfide bond with hydroxyl and the amount of catalyst stannous octoate, change the add-on of caprolactone monomer, make the polycystamine containing disulfide bond with hydroxyl The molar ratios of cystamine and caprolactone monomers were 1:15, 1:30, and 1:60, respectively. The remaining steps are the same as in Example 1.
Embodiment 3
[0043] With the experimental method of embodiment 1, fix the amount of the polycystamine containing the disulfide bond of band hydroxyl and the add-on of caprolactone monomer, change the add-on of catalyzer stannous octoate, catalyzer stannous octoate and caprolactone monomer The molar ratio of the body is 1:1000, 1:5000, 1:10000. The remaining steps are the same as in Example 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com